Article Information
- September 4, 2020.
Article Versions
- You are currently viewing Version 1 of this article (September 4, 2020 - 15:55).
- View Version 2, the most recent version of this article.
Author Information
- Gozde Sir Karakus1,#,
- Cihan Tastan1,#,
- Derya Dilek Kancagi1,#,
- Bulut Yurtsever1,#,
- Gamze Tumentemur2,
- Sevda Demir3,
- Raife Dilek Turan1,3,
- Selen Abanuz1,13,
- Didem Cakirsoy1,10,
- Utku Seyis1,
- Samed Ozer4,
- Omer Elibol5,
- Muhammer Elek1,3,
- Gurcan Ertop2,
- Serap Arbak6,
- Merve Acikel Elmas6,
- Cansu Hemsinlioglu1,
- Ayse Sesin Kocagoz7,
- Ozden Hatirnaz Ng8,
- Sezer Akyoney8,9,
- Ilayda Sahin10,11,
- Ugur Ozbek11,
- Dilek Telci3,
- Fikrettin Sahin3,
- Koray Yalcin1,12 and
- Ercument Ovali1,+
- 1Acibadem Labcell Cellular Therapy Laboratory, Istanbul, Turkey
- 2Vocational School of Health Services, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey
- 3Genetic and Bioengineering Department, Yeditepe University, Istanbul, Turkey
- 4Animal Application and Research Center, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey
- 5Acibadem Altunizade Hospital, Istanbul, Turkey
- 6Histology and Embryology Department, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey
- 7Acibadem Altunizade Hospital, Infectious Disease Unit, Istanbul, Turkey
- 8Medical Biology Department, Acibadem Mehmet Ali Aydinlar University Istanbul, Turkey
- 9Biostatistics and Bioinformatics Department, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey
- 10Medical Biotechnology Department, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey
- 11Medical Genetics Department, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey
- 12Medical Park Goztepe Hospital, Pediatric Bone Marrow Transplantation Unit, Istanbul, Turkey
- 13Medical Biochemistry Department, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey
- ↵+Correspondence
: ercument.ovali{at}acibadem.com
↵# These authors equally contributed to this study.
Author Contributions: G.S.K., C.T., D.D.K., B.Y., S.D., R.D.T., S.A., D.Ç., M.Y., R.K., and U.S. designed, completed, and/or analyzed preclinical experiments. G.T. and G.E. performed the histopathological analysis of tissues. F.Ş., D.T., D.D.K., R.D.T., and S.O. performed animal treatments. M.A.E., S.B., and S.A. performed TEM analysis. O.E., C.H., A.S.K., H.K.O., and K.Y. performed clinical specimen collection and data following. O.H.N., S.A., I.Ş. and U.Ö. performed SARS-CoV-22 genome analysis. C.T. wrote the manuscript. E.O. led the vaccine investigation and development project and contributed to the design and interpretation of the data. All authors contributed to the editing of the manuscript.